Kenya bans HIV drug

Kenya bans HIV drug


James Macharia
Kenya’s Health Minister

The Kenyan Health ministry has directed officials across the country to stop prescribing a HIV drug linked to birth defects in HIV-positive women.

The directive signed by the Director of Medical Services Jackson Kioko, urged county health directors to ensure that pregnant and breastfeeding mothers to whom a front-line drug, dolutegravir (DTG), has been prescribed, continue their current prescription until they stop breastfeeding.

But those of child bearing age between 15 and 49 years, who are on the drug, should be given the first-line treatment Efavirenz.

In a memo to county directors of health, Dr Kioko said the drug, which was launched in the Kenyan market last year, was not recommended for pregnant and breastfeeding women “due to limited safety data”.

He, however, added that through a circular in June 2017, the ministry had recommended the use of DTG in alternative regimen for people with HIV and have intolerance to Efavirenz, people who inject drugs and are on anti-retroviral therapy or new patients in the same category.

– Daily Nation

About author

You might also like

BREAKING NEWS 0 Comments

Universal access to sexual, reproductive health, key to gender equality, Osotimehin

  “Gender equality is a human right. Women are entitled to live in dignity and in freedom from want and fear, without discrimination. Gender equality is also vital to sustainable

MENTAL HEALTH 0 Comments

Arts, Politics and Mental Health

Full text of the 2015 Thomas Lambo Lecture delivered by renowned Psychiatrist and author, Dr. Femi Olugbile Protocols This is a ‘double-barreled’ assignment. One barrel is for the lecturer, representing

NEWS 0 Comments

WARIF turns orange for fight against gender-based violence

• Joins UN 16-day activism campaign   Women at Risk Foundation (WARIF), a non-profit organization, aimed at reducing the high incidence of sexual violence, rape and human trafficking in women

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply